General negative market sentiment weighed on the biotech and pharmaceutical sectors in late July 2025.
9 reports, 1 independent
Updated Aug 10
Gone quiet
- Reports
- 9
- Developments
- 3
- Repetition
- 89%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
General negative market sentiment weighed on the biotech and pharmaceutical sectors in late July 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Repligen, along with other biopharmaceutical companies, is involved in providing bioprocessing technologies and solutions for the industry.Sub-event
- Negative developments emerged on July 22, 2025, concerning the sector, including weakness in managed care providers, impacting companies like Humana and Sarepta Therapeutics.Sub-event
Sector-wide weakness in managed care and pharma equities impacted companies like Repligen and GSK.1 source
Keep exploring
The entities involved
-
Repligen
bioTech Company
Nothing else this week.
-
Humana
American managed health care company
-
Sarepta Therapeutics
biopharmaceutical company
Nothing else this week.
-
GSK
British multinational pharmaceutical and biotechnology company
Coverage
Newest first; wire copies grouped- StockStoryWhy Repligen (RGEN) Stock Is Up Today Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 7.8% in the morning session after the company reported strong second-quarter
- StockStoryWhy QuidelOrtho (QDEL) Shares Are Sliding Today Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company extended a recent losing streak a
- StockStoryWhy Are Fortrea (FTRE) Shares Soaring Today Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 24.1% in the afternoon session after positive earnings reports from industry peer
- StockStoryWhy Azenta (AZTA) Stock Is Up Today Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 5.7% in the afternoon session after the investment firm Stephens initiated coverage on the life science
- StockStoryRepligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the s